Results 21 to 30 of about 126,740 (294)
Genes, Chromosomes and Cancer, 2019 AbstractLiquid biopsy is based on minimally invasive blood tests and has a high potential to significantly change the therapeutic strategy in cancer patients, providing an extremely powerful and reliable noninvasive clinical tool for the individual molecular profiling of patients in real time.
Evi Lianidou, Klaus Pantel
openaire +3 more sources
Current clinically validated applications of liquid biopsy [PDF]
, 2022 The development of NGS technologies for the study of ctDNA has greatly broadened the possibilities of the clinical application of liquid biopsy (LB). The availability of large gene panels allows obtaining a complete genomic profile of the neoplasm even ...
Incorvaia L. +10 more
core +1 more source
Advances in liquid biopsy in neuroblastoma [PDF]
, 2022 Even with intensive treatment of high-risk neuroblastoma (NB) patients, half of high-risk NB patients still relapse. New therapies targeting the biological characteristics of NB have important clinical value for the personalized treatment of NB. However,
Zhenjian Zhuo +4 more
core +1 more source
International society of liquid biopsy (ISLB) perspective on minimal requirements for ctDNA testing in solid tumors [PDF]
: Circulating tumor DNA (ctDNA) testing has transformed precision oncology by enabling the non-invasive detection of actionable mutations. To facilitate broader clinical adoption and improve testing accuracy, standardized quality criteria must be clearly
Shetty, Omshree +16 more
core +4 more sources
Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan [PDF]
Clinical and Molecular HepatologyBackground/Aims Steatotic liver disease (SLD) is a common manifestation in chronic hepatitis C (CHC). Metabolic alterations in CHC are associated with metabolic dysfunction-associated steatotic liver disease (MASLD).
Chung-Feng Huang +14 more
doaj +1 more source
Liquid Biopsy for Investigation of Cancer DNA in Esophageal Squamous Cell Carcinoma [PDF]
, 2020 Early detection of cancer and the monitoring of cancer recurrence in treated patients are significant challenges in esophageal squamous cell carcinoma (ESCC).
Lam, AK +3 more
core +1 more source
Liquid Biopsy: Current advancements in clinical practice for bladder cancer [PDF]
Bladder cancer is the ninth most common malignancy worldwide, with two clinically distinct forms: non-muscle-invasive disease, characterized by high recurrence and excellent long-term survival, and muscle-invasive disease, associated with poorer outcomes.
Pastore AL +17 more
core +4 more sources
Computational and Structural Biotechnology Journal, 2023 Early diagnosis and progression assessment are critical for the timely detection and treatment of gastric cancer (GC) patients. Identification of diagnostic biomarkers for early detection of GC represents an unmet clinical need, and how these markers ...
Fei Long +9 more
doaj +1 more source
Precision prevention and cancer interception : the new challenges of liquid biopsy [PDF]
, 2020 : Despite major therapeutic progress, most advanced solid tumors are still incurable. Cancer interception is the active way to combat cancer onset, and development of this approach within high-risk populations seems a logical first step.
Lorente, Jose A. +14 more
core